Namwiwat Medical Corp PCL DRC (NAM_n)

Currency in THB
4.34
0.00(0.00%)
Delayed Data·

NAM_n Financial Summary

Key Ratios

P/E Ratio14.43
Price/Book1.42
Debt / Equity21.54%
Return on Equity10.97%
Dividend Yield3.47%
EBITDA240.24M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of THB (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.30%
Dividend Yield
3.46%
Industry Median 6.55%
Annualised payout
0.15
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
0.06 / --
Revenue / Forecast
538.09M / --
EPS Revisions
Last 90 days

FAQ

What were Namwiwat Medical DRC's earnings for the latest quarter?

The Namwiwat Medical DRC EPS (TTM) is 0.30. Namwiwat Medical DRC reported sales of 538.09, net income of 40.00, and EPS of 0.06 for the latest quarter.

What was Namwiwat Medical DRC's net income for the latest quarter?

Namwiwat Medical DRC's net income for the latest quarter was 40.00.

How did Namwiwat Medical DRC's performance compare year-over-year in the latest quarter?

The company's revenue moved from 372.60 in the previous quarter to 538.09 in the latest quarter, and net income moved from 56.70 to 40.00 compared to the previous quarter.

What is Namwiwat Medical DRC's net profit margin on a TTM basis?

Namwiwat Medical DRC's trailing twelve months (TTM) net profit margin is 16.20%.

How does Namwiwat Medical DRC's debt to equity ratio compare to industry standards?

Namwiwat Medical DRC's total debt-to-equity ratio is 21.54%.

What is Namwiwat Medical DRC's return on investment on a TTM basis?

Namwiwat Medical DRC's trailing twelve months (TTM) return on investment (ROI) is 10.97%.

Did Namwiwat Medical DRC gain or lose cash last quarter?

In the latest quarter, Namwiwat Medical DRC's net change in cash was -34.18 million.

What were Namwiwat Medical DRC's total assets and liabilities in the latest quarter?

As of the latest quarter, Namwiwat Medical DRC reported total assets of 3,169.91 million and total liabilities of 789.72 million.

How has Namwiwat Medical DRC's total revenue grown this year?

Namwiwat Medical DRC's total revenue was 372.60 in the previous quarter and 538.09 in the latest quarter.

What is Namwiwat Medical DRC's gross margin on a TTM basis?

Namwiwat Medical DRC's trailing twelve months (TTM) gross margin is 37.76%.

What was Namwiwat Medical DRC's revenue per share for the latest quarter?

Namwiwat Medical DRC's revenue per share for the latest quarter was 6.71.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.